Biblio
MEIS inhibitors reduce the viability of primary leukemia cells and Stem cells by inducing apoptosis. Leuk Lymphoma. 2023:1-12.
. Therapeutic targeting and HSC proliferation by small molecules and biologicals. Adv Protein Chem Struct Biol. 2023;135:425-496.
. BML-260 promotes the growth of cord blood and mobilized peripheral blood hematopoietic stem and progenitor cells with improved reconstitution ability. J Cell Biochem. 2022.
. Competitive inhibition of IL-2/IL-2R has a dual effect on HSC ex vivo expansion and IL-2R (CD25) content. Int Immunopharmacol. 2022;110:109035.
. .